DEF: USA Rare Earth Seeks Shareholder Approval for Major Warrant Issuance Tied to $75 Million Private Placement

USA Rare Earth, Inc. is calling a special stockholder meeting on July 1, 2025, to approve the issuance of up to 10,714,286 common shares related to a warrant from a recent $75 million private placement, as required by Nasdaq listing rules.

Summary

• USA Rare Earth, Inc. (USAR) will hold a virtual Special Meeting of stockholders on July 1, 2025, at 9:00 a.m. Central Time.
• The primary purpose is to seek stockholder approval for the issuance of up to 10,714,286 shares of common stock pursuant to a Common Warrant issued to an institutional investor.
• This warrant was part of a private placement transaction that closed on May 2, 2025, which raised total gross proceeds of $75,000,000.
• The private placement included the issuance of 8,550,400 shares of Common Stock, a pre-funded warrant for 2,163,886 shares, and the Common Warrant for 10,714,286 shares.
• Stockholder approval is required under Nasdaq Listing Rule 5635(d) because the potential issuance from the Common Warrant, combined with other shares from the private placement, exceeds 20% of the company's outstanding common stock (totaling 21,428,572 shares, or over 20% of 82,068,160 shares outstanding pre-transaction).
• Additionally, the transaction's price was lower than the five-day average Nasdaq Official Closing Price of $11.89 per share preceding the signing of the agreement.
• The Common Warrant has an exercise price of $7.00 per share and is exercisable for a period of six years, subject to adjustments.
• The meeting will also seek approval for an Adjournment Proposal, allowing the meeting to be postponed if insufficient votes are received for the Warrant Share Issuance Proposal.
• Certain stockholders, including directors and officers, collectively representing approximately 50.3% of the aggregate voting power as of the May 23, 2025 record date, have signed support agreements to vote in favor of the Warrant Share Issuance Proposal.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. While the document is procedural, it confirms a significant capital raise ($75M) has been completed, which is a positive for the company's financial position. The board's unanimous recommendation and pre-secured majority vote from key shareholders for the warrant issuance indicate strong internal alignment and a high likelihood of approval, reducing uncertainty. The potential for dilution is noted, but it's a consequence of capital raising. The need for future meetings if approval fails is a minor negative, but the support agreements mitigate this risk.

Positives

• The company successfully completed a private placement transaction on May 2, 2025, raising significant gross proceeds of $75,000,000.
• The Board of Directors unanimously recommends that stockholders vote in favor of the Warrant Share Issuance Proposal and the Adjournment Proposal, indicating strong internal support.
• Stockholder support agreements from key insiders and large shareholders, representing over 50% of the voting power, significantly increase the likelihood of the Warrant Share Issuance Proposal passing.
• The Common Warrant provides the company with potential future capital infusion if exercised, and its terms include anti-dilution and participation rights for the holder in certain corporate events.

Negatives

• The issuance of up to 10,714,286 shares upon exercise of the Common Warrant represents a significant potential dilution to existing common stockholders.
• The exercise price of the Common Warrant at $7.00 per share is substantially lower than the five-day average Nasdaq Official Closing Price of $11.89 per share prior to the private placement signing, indicating the shares were issued at a discount.
• Failure to obtain stockholder approval for the Warrant Share Issuance Proposal would require the company to hold additional special meetings semi-annually until approval is secured, indicating a potential ongoing procedural burden and uncertainty.

Risks

• Failure to obtain stockholder approval for the Warrant Share Issuance Proposal could lead to ongoing requirements for the company to hold additional special meetings semi-annually until such approval is obtained, potentially diverting management resources and creating uncertainty.
• The terms of the Common Warrant include provisions for adjustments to the exercise price and number of shares issuable, including reductions if the company issues common stock or equivalents at a price lower than the then-current exercise price, which could lead to further dilution.
• The Common Warrant provides for cashless exercise under certain conditions and may require payments from the company for failure to deliver shares, posing potential liquidity risks.
• The company is subject to Nasdaq Listing Rule 5635(d), and non-compliance due to lack of stockholder approval could have adverse implications for its listing status.

Future Outlook

If stockholder approval for the Warrant Share Issuance Proposal is not obtained at the Special Meeting, the company is required to hold an additional special meeting by September 30, 2025. Should approval still not be secured, the company will be obligated to convene semi-annual stockholder meetings thereafter until the necessary approval is achieved.

Management Comments

• Joshua Ballard, CEO and Director, stated: 'Your vote is very important regardless of the number of shares of Common Stock and/or Series A Preferred Stock that you own. Whether or not you expect to virtually attend the Special Meeting, please submit your proxy or voting instructions as soon as possible... so that your shares may be represented at the Special Meeting.'
• The Board of Directors unanimously recommends that stockholders vote FOR the Warrant Share Issuance Proposal and the Adjournment Proposal.

Industry Context

This announcement primarily concerns a specific corporate finance and governance action for USA Rare Earth, Inc., rather than broad industry trends. The private placement and subsequent need for shareholder approval for warrant issuance are standard procedures for publicly traded companies raising capital, especially when the terms trigger exchange listing rules related to potential dilution. The company's focus on rare earth elements places it within the critical minerals sector, which is strategically important, but this filing does not provide specific updates on its operational or market position within that industry.

Comparison to Industry Standards

• The requirement for shareholder approval due to the issuance exceeding 20% of outstanding shares at a discount to market price is a standard compliance measure under Nasdaq Listing Rule 5635(d), common across U.S. listed companies undertaking significant capital raises or equity-linked transactions.
• The structure of the private placement, involving common stock, pre-funded warrants, and warrants, is a common financing mechanism used by companies, particularly in growth-oriented sectors, to raise capital while managing immediate dilution and providing upside potential to investors.
• The inclusion of stockholder support agreements from key insiders and large shareholders, representing a majority of voting power, is a common practice to ensure the successful passage of critical corporate proposals, aligning with best practices for securing shareholder consent in significant transactions.

Corporate Governance

Related Party Transactions

• Certain stockholders of the Company, including certain directors or officers (Michael Blitzer, Paul Kern, Tready Smith, David Kronenfeld, Steve Ridge, and The Critical Minerals Trust, an affiliate of director Mordechai Gutnick), have executed stockholder support agreements with the Purchaser to vote their shares in favor of the Warrant Share Issuance Proposal. These individuals collectively represent a majority of the company's voting power.

Stakeholder Impact

• **Shareholders**: Potential dilution from the exercise of the Common Warrant (up to 10,714,286 shares) if approved. However, the private placement itself provided $75 million in gross proceeds, which could strengthen the company's financial position. Shareholders are being asked to vote on a significant equity issuance.
• **Institutional Investor (Purchaser)**: The Purchaser benefits from the Common Warrant, which allows them to acquire a substantial number of shares at a fixed exercise price of $7.00 per share for six years, with protective adjustments and rights in fundamental transactions. Their ability to exercise the warrant is contingent on stockholder approval.
• **Company Operations**: The capital raised from the private placement provides funding for the company's operations and strategic initiatives. The successful approval of the warrant issuance ensures the full terms of the private placement can be realized.

Next Steps

• Stockholders are encouraged to submit their proxy or voting instructions by internet, telephone, or mail as soon as possible.
• The Special Meeting of stockholders will be held virtually on July 1, 2025, to vote on the Warrant Share Issuance Proposal and the Adjournment Proposal.
• If stockholder approval for the Warrant Share Issuance Proposal is not obtained, the company is required to hold an additional special meeting by September 30, 2025, and semi-annually thereafter until approval is secured.
• Preliminary voting results will be announced at the Special Meeting if known, or disclosed on a Current Report on Form 8-K within four business days.
• Final voting results will be disclosed on an amendment to the Current Report on Form 8-K within four business days after results are known.

Key Dates

Keywords

Rare Earth, SEC Filing, Proxy Statement, Private Placement, Warrant Issuance, Stockholder Approval, Nasdaq Listing Rule 5635(d), Common Stock, Series A Preferred Stock, Corporate Governance, Dilution, Capital Raise